• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX2; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX2; BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA22-60/I16-40
Device Problem Deformation Due to Compressive Stress (2889)
Patient Problems Extravasation (1842); Low Blood Pressure/ Hypotension (1914); Vascular Dissection (3160)
Event Date 12/28/2022
Event Type  Injury  
Manufacturer Narrative
The device remains implanted in the patient; therefore, it will not be returned for evaluation.Patient medical records and imaging studies will be requested for further evaluation by the clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Device iteration is afx2 h3 other text : device remains implant.
 
Event Description
Afx2 bifurcated device implant procedure; device wouldn¿t advance into the tight aorta.The physician elected to retract the afx2 device back into the introducer sheath and in doing so the distal part of the sheath created a kink in the component.Extravasation was noticed and the patient's blood pressure dropped.An open repair of the external iliac was performed.The final patient status was reported as doing good.
 
Manufacturer Narrative
The reported event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported event/incident-related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported event/incident.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the afx 2, introducer device damaged during use, difficult to withdraw, and kinked components are confirmed.This is consistent with the reported event/incident.The complaint is most likely user related.The identified harms related to the procedure include an avulsed right external iliac artery and a common femoral artery which required an additional surgical procedure for open repair of the right external iliac artery.It is noteworthy that there was no abdominal aortic aneurysm and aortoiliac occlusive disease (off-label), which may have contributed to the reported event.This case was an off-label intervention with a right common iliac artery distal diameter of 7.1mm and a left common iliac artery distal diameter of 9.1mm lcia d 9.1mm (which should be within 10-23mm range).The minimal access on the right was 4.2mm and on the left was 4.2 mm (which should be greater than 6.5mm, off-label), and this likely contributed to the reported events.The neck diameter was 12.7 mm (which should be within 18-32mm range, off-label).Furthermore, the presence of thickened calcifications in the right common iliac artery was found to have likely contributed to the reported avulsion (perforation).The final patient status was reported as doing good.No additional investigation of this reported event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar events/incidents.Device iteration is afx2.G3: date of received by manufacturer has been updated h3: reason device not evaluated has been updated h6: investigation finding codes: remove code 3233 h6: investigation conclusion code: remove code 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
Manufacturer (Section G)
ENDOLOGIX
2 musick
,
irvine CA 92618
Manufacturer Contact
gary kirchgater
2 musick
,
irvine, CA 92618
8009832284
MDR Report Key16219600
MDR Text Key307875738
Report Number2031527-2023-00010
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00818009015013
UDI-Public(01)00818009015013(17)231006
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 12/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/06/2023
Device Model NumberBEA22-60/I16-40
Device Lot Number2392704-002
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/28/2022
Initial Date FDA Received01/20/2023
Supplement Dates Manufacturer Received02/21/2023
Supplement Dates FDA Received03/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/06/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AFX AFX INTRODUCER SYSTEM II 2491555014; AFX INTRODUCER SYSTEM II 2489353009; AFX2 BIFURCATED STENT GRAFT 2582018006; OVATION IX EXTENDER FS050322-48
Patient Outcome(s) Required Intervention;
Patient Age78 YR
Patient SexFemale
-
-